化学
顺铂
DNA
药品
DNA损伤
核苷酸
癌细胞
细胞凋亡
生物化学
硫黄
硫醇
程序性细胞死亡
癌症
纳米颗粒
细胞毒性
活性氧
细胞
药物发现
下调和上调
癌症治疗
银纳米粒子
小分子
生物物理学
细胞生物学
加合物
细胞生长
基因组不稳定性
药理学
平衡
细胞培养
致癌物
DNA氧化
双重角色
硫代谢
纳米技术
作者
Yue Li,Qiong Wang,Honghuan Xia,Fengbang Wang,Peng Jiao,Maoyong Song,Guibin Jiang
出处
期刊:Nano Letters
[American Chemical Society]
日期:2026-02-18
卷期号:26 (13): 4353-4361
被引量:2
标识
DOI:10.1021/acs.nanolett.5c06237
摘要
Numerous nanoparticles (NPs) have emerged as promising physical vehicles to deliver drugs for cancer treatment, yet the effect of their biochemical activities on drug efficacy is rarely considered. Here, we demonstrate that silver nanoparticles (AgNPs) specially potentiate the anticancer efficacy of platinum-based drugs, increasing apoptosis rates by up to 5.26-fold across multiple cancer cell lines. Untargeted metabolomics identified the AgNPs-induced downregulation of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) and glutathione, key components of sulfur metabolism, alongside depletion of nucleotide pools critical for DNA repair. The dual action─reducing thiol-containing molecules to decrease drug inactivation while reducing nucleotide to inhibit DNA repair─led to elevated Pt-DNA adducts and exacerbated DNA damage. In vivo, AgNPs-cisplatin cotreatment suppressed tumor growth compared to cisplatin alone, accompanied by reduced thiol level and increased platinum accumulation in the tumor. Our findings highlight that the match of nanoparticle and drug in their biochemical activities will maximize the therapeutic efficacy for cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI